Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity.

Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

1965 • 2,890 citations

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1977 • 1,526 citations

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1982 • 1,079 citations

Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting

1981 • 707 citations

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

1984 • 401 citations

Peripheral sensory neuropathy and cisplatin chemotherapy

1984 • 368 citations

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

1975 • 346 citations

High-Dose Cisplatin in Hypertonic Saline

1984 • 335 citations

VP-16 and cisplatin as first-line therapy for small-cell lung cancer.

1985 • 301 citations

Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian Cancer

1990 • 287 citations

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721

1988 • 217 citations

Antiemetic Efficacy of Dexamethasone

1984 • 179 citations

Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors

1984 • 136 citations

Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.

1988 • 122 citations

Carboplatin: current status and future prospects

1988 • 101 citations

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

1987 • 96 citations

COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA

1979 • 96 citations

High-dose cisplatin therapy in ovarian cancer.

1985 • 92 citations

Lead Encephalopathy in Neonatal Long-Evans Rats: Morphologic Studies

1977 • 90 citations

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity.

1985 • 79 citations

Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity.

1985 • 66 citations

Cisplatin-induced autonomic neuropathy.

1984 • 59 citations

The renal toxicity of cancer chemotherapeutic agents

1982 • 58 citations

Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II

1980 • 53 citations

Prospective nerve conduction studies in cisplatin therapy

1988 • 46 citations

Cellular distribution of cis-diamminedichloroplatinum(II)-DNA binding in rat dorsal root spinal ganglia: Effect of the neuroprotecting peptide ORG.2766

1989 • 34 citations

Local neurotoxicity after intra-arterial cisplatin in head and neck cancer.

1987 • 24 citations

CISPLATINUM NEUROTOXICITY IN FERRETS

1989 • 4 citations